Bio-Techne Rebrands Atlanta Biologicals Serum And Media As Part Of The R&D Systems Product PortfolioHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Bio-Techne Rebrands Atlanta Biologicals Serum And Media As Part Of The R&D Systems Product PortfolioPR NewswireJanuary 7, 2020ReblogShareTweetShareMINNEAPOLIS, Jan. 7, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that the Atlanta Biologicals portfolio of serum and media will be rebranded as R&D Systems. As part of the rebranding, the Atlanta Biologicals website will be retired and the entire serum and media portfolio, including product details and purchasing options, will be maintained through the R&D Systems website. Currently all serum and media products can be purchased through R&D Systems.Dave Eansor, President of Bio-Techne's Protein Sciences Segment, commented, "We are excited to consolidate the Atlanta Biologicals portfolio within R&D Systems' extended offering of cell culture solutions. By rolling the Atlanta Biologicals brand into R&D Systems, researchers will benefit from ensured product quality, an expanded portfolio of culture regents and an experience that enables the purchase of media, serum, proteins, antibodies, and more from a single, trusted source."More information on the rebranding and retirement of Atlanta Biologicals can be found at https://www.rndsystems.com/atlanta-biologicals-now-rd-systemsAbout Bio-Techne Corporation (NASDAQ: TECH) Contact:
David Clair, Senior Director, Corporate Development
david.clair@bio-techne.com
612-656-4416
Bio-TechneMore CisionMoreView original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-rebrands-atlanta-biologicals-serum-and-media-as-part-of-the-rd-systems-product-portfolio-300979866.htmlSOURCE Bio-Techne CorporationReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance Video'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceQ4 e-commerce sales are what's 'saving Walmart': AnalystYahoo Finance VideoBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo FinanceWhat to watch in the markets: Friday, February 28Yahoo Finance VideoHackers Breach Ring Home Security CamerasYahoo Finance Video